112 related articles for article (PubMed ID: 30273915)
1. A new ligand of CD105 screened out by phage display technology provides a reliable identification of recurrent or metastasizing pleomorphic adenoma from pleomorphic adenoma.
Yu M; Li X; Liang R; Yang J; Zhang Y; Wang H
Int Immunopharmacol; 2018 Dec; 65():37-43. PubMed ID: 30273915
[TBL] [Abstract][Full Text] [Related]
2. PLAG1 expression is maintained in recurrent pleomorphic adenoma.
de Brito BS; Gaspar NG; Egal ES; Sanchez-Romero C; Martins AS; Tincani ÁJ; de Oliveira Gondak R; de Almeida OP; Kowalski LP; Altemani A; Mariano FV
Virchows Arch; 2016 Oct; 469(4):477-81. PubMed ID: 27381214
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.
Soares AB; de Araújo VC; Juliano PB; Altemani A
J Oral Pathol Med; 2009 Sep; 38(8):623-9. PubMed ID: 19563505
[TBL] [Abstract][Full Text] [Related]
4. Increase in Chymase-Positive Mast Cells in Recurrent Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland.
Kinoshita I; Jin D; Higashino M; Terada T; Kurisu Y; Takai S; Kawata R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884420
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
7. Metastasising pleomorphic adenoma: Systematic review.
Knight J; Ratnasingham K
Int J Surg; 2015 Jul; 19():137-45. PubMed ID: 25958295
[TBL] [Abstract][Full Text] [Related]
8. Estrogen, Progesterone and Androgen Receptor in Primary and Recurrent Pleomorphic Salivary Adenomas.
Tarakji B; Mehsen Alali F
Asian Pac J Cancer Prev; 2023 May; 24(5):1731-1735. PubMed ID: 37247295
[TBL] [Abstract][Full Text] [Related]
9. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.
Soares AB; Altemani A; de Araújo VC
J Oral Pathol Med; 2011 Apr; 40(4):352-8. PubMed ID: 20969626
[TBL] [Abstract][Full Text] [Related]
10. An intracapsular carcinoma ex pleomorphic adenoma with lung metastases composed exclusively of benign elements: histological evidence of a continuum between metastasizing pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Weissferdt A; Langman G
Pathol Res Pract; 2010 Jul; 206(7):480-3. PubMed ID: 19665316
[TBL] [Abstract][Full Text] [Related]
11. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
12. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
13. A case of metastasizing pleomorphic adenoma in the maxillary bone appearing twenty years after initial resection of pleomorphic adenoma of the hard palate.
Akiba J; Harada H; Kawahara A; Todoroki K; Nagata S; Yano H
Pathol Int; 2013 Sep; 63(9):463-8. PubMed ID: 24200158
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
15. The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Tincani AJ; Martins AS; Altemani A; de Araújo VC
J Clin Pathol; 2012 Mar; 65(3):272-7. PubMed ID: 22174424
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
17. Somatic copy number alterations in pleomorphic adenoma and recurrent pleomorphic adenoma.
Mariano FV; Fidalgo F; Casarim ALM; Martins AS; Scarini JF; de Lima Souza RA; Egal ES; Kowalski LP; Krepischi ACV; Altemani A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Jan; 129(1):59-64. PubMed ID: 31607675
[TBL] [Abstract][Full Text] [Related]
18. Expression of hormonal receptor in patients with metastasizing pleomorphic adenoma of the major salivary gland; a clinicopathological report of three cases.
Larbcharoensub N; Cert PK; Tungkeeratichai J; Prakunhungsit S; Narkwong L; Leopairut J
J Med Assoc Thai; 2009 Sep; 92(9):1250-5. PubMed ID: 19772187
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
Miao Y; Zong M; Jiang T; Yuan X; Guan S; Wang Y; Zhou D
Pituitary; 2016 Apr; 19(2):194-201. PubMed ID: 26809958
[TBL] [Abstract][Full Text] [Related]
20. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
